Australia Huntington’s Disease Market Analysis


  • Type: Rare Disease Area
  • Published : April 2021
  • Region: APAC
  • Country: Australia
  • Report ID : 4097

  • Format: PPT, PDF

Australian Huntington Disease Therapeutics Market: Segmented by Diagnosis, Therapeutics, and Route of Administration – Size, Share, Impact, Growth, Trends, and Forecasts (2020 – 2028F)

SKU: 4097 Categories: ,

Report Overview

The Australian Huntington Disease (HD) Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Huntington disease (HD) is an inherited condition characterized by the progressive degeneration of neurons within certain areas of the brain (e.g., basal ganglia, cerebral cortex). People with HD usually live for about 15 to 20 years after the condition begins. Signs and symptoms usually develop between ages 35 to 44 years and may include uncontrolled movements, loss of intellectual abilities, and various emotional and psychiatric problems.

About six people per 100,000 are affected by Huntington’s Disease. In Australia over 2,500 people have Huntington’s Disease.

Market Growth Drivers

High unmet needs within the market present a key commercial opportunity to develop breakthrough disease-modifying therapies. The introduction of disease-modifying drugs is poised to transform the market landscape. With ongoing research, there are increasingly significant opportunities for drug companies to develop new drugs with novel mechanisms of action.

The Huntington’s Disease Therapeutics market is expected to witness novel product launches, including approval of several disease-modifying therapies. Current research in HD focuses on using novel treatments such as immuno-modulating therapies, gene therapy (using antisense oligonucleotides, micro RNAs (miRNA), mRNA splicing, and zinc-finger DNA binding protein).

Increasing incidence and prevalence of Huntington Disease is one of the major key driver of HD market growth over the forecast period. Wave Life Sciences and Roche’s antisense oligonucleotides aim to target underlying disease cause and are expected to contribute significantly to market growth.

However, increase in cost of medical treatment, less prominent reimbursement policies and occurrence of side effects in related current available treatments may hamper the Huntington disease treatment market growth.

1. Australian Huntington Disease Therapeutics Market Overview…………………
A. Market Size
2. Market Growth Drivers……………………………………….………………………………………………….
A. Rising Research & Development Activities boosts the Market Growth
B. Surge in Incidence and Prevalence of Huntington Disease
C. Increasing Adoption of Novel Therapeutics & Technological Advancements
3. Major Types of Huntington Disease………………………………………………………………..
A. Juvenile Huntington Disease
B. Adult-onset Huntington Disease
4. Huntington Disease Therapeutics Market Segmentation……………………………..
A. By Diagnosis
I. Computerised Tomography (CT) Scanning
II. Magnetic Resonance Imaging (MRI)
III. Electroencephalography (EEG)
IV. Neuropsychological Tests
V. Genetic Tests
VI. Others
B. By Therapeutics
I. Psychotherapy
II. Speech Therapy
III. Physiotherapy
IV. Antidopaminergics
V. Anticonvulsants
VI. Antipsychotics
VII. Antidepressants
VIII. Others
C. By Route of Administration
I. Oral
II. Intravenous (IV)
III. Intrathecal (IT)
IV. Others
5. Huntington Disease Major Drugs Market Share……………………………………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………………………….
A. Major Players
B. Products in Pipeline
7. Key Company Profiles……………………………………………………………………………….
A. Roche Company overview, Product & Services, Strategies & Financials
B. Ionis Company overview, Product & Services, Strategies & Financials
C. Teva Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth…………………………………………………………….
A. New Trends and Development of Huntington Disease Therapeutics Market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Diagnosis:

Based on diagnosis, the HD Therapeutics market is segmented into computerized tomography (CT) scanning, magnetic resonance imaging (MRI), electroencephalography (EEG), neuropsychological tests, genetic tests, and others. As the prevalence of Huntington Disease enhances, thus it can be projected that HD market growth will increase over the forecast period.

By Therapeutics:

In terms of therapeutics, the HD Therapeutics market can be classified into Psychotherapy, Speech therapy, Physiotherapy, Antidopaminergics, Anticonvulsants, Antipsychotics, and Antidepressants, etc. iNova tetrabenazine (tetrabenazine) and Austedo (deutetrabenazine) are two antidopaminergic medications approved to treat symptoms of chorea in Huntington’s disease. Thus, projected to exhibit strong growth during the forecast period.

By Route of Administration:

Based on route of administration, the HD Therapeutics market can be segmented into oral, intravenous (IV), intrathecal (IT), and others. Various drugs can be administered at regular intervals to the patients with Huntington disease. The intrathecal type of the route of administration segment is anticipated to account for the majority of the revenue share during the forecast period.

Top Major Players

The Australian Huntington Disease Therapeutics market is highly competitive and provides a great opportunity for market players to account the maximum market share.  The prominent players in the HD treatment market include Hoffmann La-Roche Ltd, iNova Pharmaceuticals (Australia) Pty Ltd., Teva Pharmaceuticals UK Ltd, Ionis Pharmaceuticals Inc. among others.


Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements